Dorina van der kolk
Dorina van der kolk
Clinical Genetics, University Medical Centre Groningen
Verified email at umcg.nl
Title
Cited by
Cited by
Year
Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone-and topotecan-resistant cell lines
GL Scheffer, M Maliepaard, ACLM Pijnenborg, MA van Gastelen, ...
Cancer research 60 (10), 2589-2593, 2000
2462000
Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age
DM van der Kolk, GH de Bock, BK Leegte, M Schaapveld, MJE Mourits, ...
Breast cancer research and treatment 124 (3), 643-651, 2010
1842010
Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia
DM van der Kolk, E Vellenga, GL Scheffer, M Müller, SE Bates, ...
Blood, The Journal of the American Society of Hematology 99 (10), 3763-3770, 2002
1622002
P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia
DM van der Kolk, EGE de Vries, WLJ van Putten, LF Verdonck, ...
Clinical cancer research 6 (8), 3205-3214, 2000
1262000
Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and normal hematopoietic CD34+ peripheral blood cells.
DM van der Kolk, EG De Vries, JA Koning, E van den Berg, M Müller, ...
Clinical Cancer Research 4 (7), 1727-1736, 1998
1011998
The role of drug efflux pumps in acute myeloid leukemia
DM van der Kolk, EGE de Vries, M Müller, E Vellenga
Leukemia & lymphoma 43 (4), 685-701, 2002
992002
Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells
D van Gosliga, H Schepers, A Rizo, D van der Kolk, E Vellenga, ...
Experimental hematology 35 (10), 1538-1549, 2007
862007
Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia
DM Van der Kolk, EGE de Vries, L Noordhoek, E Van Den Berg, ...
Leukemia 15 (10), 1544-1553, 2001
842001
Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation
R Boonstra, H Timmer-Bosscha, J van Echten-Arends, DM van der Kolk, ...
British journal of cancer 90 (12), 2411-2417, 2004
752004
ATP binding cassette transporter gene expression in rat liver progenitor cells
JE Ros, TAD Roskams, M Geuken, R Havinga, PL Splinter, BE Petersen, ...
Gut 52 (7), 1060-1067, 2003
732003
The role of breast cancer resistance protein in acute lymphoblastic leukemia
SLA Plasschaert, DM van der Kolk, ESJM de Bont, WA Kamps, K Morisaki, ...
Clinical cancer research 9 (14), 5171-5177, 2003
662003
High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children
SLA Plasschaert, E Vellenga, ESJM de Bont, DM van der Kolk, ...
Leukemia & lymphoma 44 (1), 85-95, 2003
522003
Multidrug resistance protein MRP1, glutathione, and related enzymes
DM van der Kolk, E Vellenga, M Müller, EGE de Vries
Drug resistance in leukemia and lymphoma III, 187-198, 1999
421999
Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1
BAP Van Gorkom, H Timmer-Bosscha, S De Jong, DM Van der Kolk, ...
British journal of cancer 86 (9), 1494-1500, 2002
412002
Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity
DM van der Kolk, E Vellenga, AY van der Veen, L Noordhoek, ...
Blood, The Journal of the American Society of Hematology 95 (11), 3514-3519, 2000
392000
Breast Cancer Resistance Protein (BCRP) in Acute Leukaemia
SLA Plasschaert, DM Van Der Kolk, ESJM De Bont, E Vellenga, ...
Leukemia & lymphoma 45 (4), 649-654, 2004
382004
Selective expression of cholesterol metabolism genes in normal CD34+ CD38− cells with a heterogeneous expression pattern in AML cells
SD Peeters, DM van der Kolk, G de Haan, L Bystrykh, F Kuipers, ...
Experimental hematology 34 (5), 622-630, 2006
342006
Breast cancer incidence after risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers
IE Fakkert, MJE Mourits, L Jansen, DM van der Kolk, K Meijer, ...
Cancer Prevention Research 5 (11), 1291-1297, 2012
232012
Proven non-carriers in BRCA families have an earlier age of onset of breast cancer
JR Vos, GH de Bock, N Teixeira, DM van der Kolk, L Jansen, MJE Mourits, ...
European Journal of Cancer 49 (9), 2101-2106, 2013
162013
Ovarian cancer in BRCA1/2 mutation carriers: The impact of mutation position and family history on the cancer risk
N Teixeira, MJE Mourits, JR Vos, DM van der Kolk, L Jansen, ...
Maturitas 82 (2), 197-202, 2015
112015
The system can't perform the operation now. Try again later.
Articles 1–20